Related Experiment Video
Updated: Jun 12, 2025

09:32
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
11.7K
Protocol for isolating antigen-specific monoclonal antibodies from immunized mice utilizing the Beacon platform.
Meilan Fu1, Xiangwei Wang1, Shubing Tang2
1Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
STAR Protocols
|October 13, 2024
Summary
The Beacon platform enables efficient isolation of antigen-specific plasma B cells. This protocol details using Beacon to isolate cells, sequence B cell receptors (BCRs), and express antibodies, applicable to human samples.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Isolating antigen-specific plasma B cells has historically been difficult.
- The Beacon platform offers a novel solution using light-sorting technology.
- High-throughput screening of single cells for specific antigen recognition is now feasible.
Purpose of the Study:
- To present a detailed protocol for isolating antigen-specific plasma B cells.
- To demonstrate the application of the Beacon platform for B cell receptor (BCR) sequencing.
- To outline the subsequent cloning and expression of antibodies derived from these B cells.
Main Methods:
- Utilized the Beacon platform for high-throughput, single-cell sorting based on antigen specificity.
- Employed sequencing techniques to determine the B cell receptors (BCRs) from isolated plasma B cells.
- Performed molecular cloning and expression of antibodies encoded by the identified BCRs.
Main Results:
- Successfully isolated antigen-specific plasma B cells from immunized mouse models.
- Obtained sequences for B cell receptors (BCRs) from the sorted single cells.
- Expressed functional antibodies derived from the isolated and sequenced B cells.
Conclusions:
- The Beacon platform provides an effective method for isolating antigen-specific plasma B cells.
- This protocol facilitates the discovery and development of novel antibodies.
- The methodology is adaptable for use with human samples, broadening its potential applications.

